Posts by jootooru@gmail.com

Lab technician conducting a MSAC funded diagnostic test

5 Common Mistakes Sponsors Make in MSAC Submissions for Diagnostic and Investigative Technologies

4 months ago

For sponsors seeking public reimbursement in Australia, submissions for diagnostic and investigative technologies present a fundamentally different challenge to therapeutic services. Under the Medical Services Advisory Committee (MSAC) framework, diagnostic…

Market Access Discussion Forum: PBAC IO Broad Listing Case Study

Uncategorized

5 months ago

Attend our Market Access Discussion Forum tailored for professionals in the pharmaceutical industry! This event provides a unique platform to network with fellow experts and engage in in-depth discussions on…

Pulse Economics joins national Advanced Therapies Advisory Group

News

5 months ago

Pulse Economics is pleased to share that Oona Reardon, Managing Director, has been appointed as a member of the newly established Medicines Australia and AusBiotech Advanced Therapies Advisory Group. The Advisory Group brings together industry, policy and…

Top 8 things medical device companies need to know after the Prescribed List reforms

Insights

5 months ago

For medical device companies seeking reimbursement in the Australian private hospital system, inclusion on the Prescribed List (PL) remains critical. What has changed is that the Prescribed List is no…

Lived experience and diabetes technology

News

7 months ago

The Diabetes Australia Grand Innovation Challenge launches today and it’s tackling something the sector desperately needs. Australia is in short supply of early-stage funding for medtech and digital health solutions…

MFN 2.0: How the US GENEROUS model could quietly reshape global pricing and put Australia on the back foot

News

7 months ago

On 6 November 2025, the US Centers for Medicare & Medicaid Services (CMS) announced the GENEROUS (GENErating cost Reductions fOr US Medicaid) Model, a 5-year voluntary pilot starting in 2026.…

What pharma companies need to know about the new PBS Notice of Intent requirements

News

9 months ago

The Department of Health, Disability and Ageing has announced changes to their PBS Notice of Intent (NOI) process that will impact your market access timeline and preparation strategy for submissions…

Market Access Forum for Pharma Industry Professionals

Uncategorized

9 months ago

Attend our Market Access Forum tailored for professionals in the pharmaceutical industry! This event provides a unique platform to network with fellow experts and engage in in-depth discussions on various…

We’ve joined the National AI Centre’s AI Directory

News

10 months ago

Exciting news! Pulse Economics is proud to be listed on the National AI Centre’s AI Directory, a platform showcasing Australia’s AI capabilities across industries and technologies. As commercialisation strategy experts,…

Future proofing HTA: critical conversations for Australian healthcare

News

11 months ago

Key challenges and opportunities shaping health technology assessment Next Tuesday’s ISPOR workshop brings together Australia’s leading HTA stakeholders: PBAC members, HTA Review Implementation Advisory Committee representatives, academics, and industry experts…